196 related articles for article (PubMed ID: 22736773)
1. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
[TBL] [Abstract][Full Text] [Related]
2. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
[TBL] [Abstract][Full Text] [Related]
3. Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma.
Kallel R; Belguith-Maalej S; Akdi A; Mnif M; Charfeddine I; Galofré P; Ghorbel A; Abid M; Marcos R; Ayadi H; Velázquez A; Hadj Kacem H
Cancer Biomark; 2010-2011; 8(1):43-51. PubMed ID: 21896990
[TBL] [Abstract][Full Text] [Related]
4. Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
Mond M; Bullock M; Yao Y; Clifton-Bligh RJ; Gilfillan C; Fuller PJ
Thyroid; 2015 Aug; 25(8):904-10. PubMed ID: 25950909
[TBL] [Abstract][Full Text] [Related]
5. Association of FOXE1 polyalanine repeat region with thyroid cancer is dependent on tumour size.
Raimundo J; Alvelos MI; Azevedo T; Martins T; Rodrigues FJ; Lemos MC
Clin Endocrinol (Oxf); 2017 Feb; 86(2):243-246. PubMed ID: 27474100
[TBL] [Abstract][Full Text] [Related]
6. FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.
Tomaz RA; Sousa I; Silva JG; Santos C; Teixeira MR; Leite V; Cavaco BM
Clin Endocrinol (Oxf); 2012 Dec; 77(6):926-33. PubMed ID: 22882326
[TBL] [Abstract][Full Text] [Related]
7. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
[TBL] [Abstract][Full Text] [Related]
8. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
[TBL] [Abstract][Full Text] [Related]
9. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma.
Fan Y; Ding Z; Yang Z; Deng X; Kang J; Wu B; Zheng Q
Mol Med Rep; 2013 Jul; 8(1):123-7. PubMed ID: 23715628
[TBL] [Abstract][Full Text] [Related]
10. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S
Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
[TBL] [Abstract][Full Text] [Related]
12. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
13. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
14. The investigation of foxe1 variations in papillary thyroid carcinoma.
Somuncu E; Karatas A; Ferahman S; Saygili N; Yilmaz E; Ozturk O; Kapan M
Int J Clin Exp Pathol; 2015; 8(10):13458-64. PubMed ID: 26722557
[TBL] [Abstract][Full Text] [Related]
15. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
16. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
Landa I; Ruiz-Llorente S; Montero-Conde C; Inglada-Pérez L; Schiavi F; Leskelä S; Pita G; Milne R; Maravall J; Ramos I; Andía V; Rodríguez-Poyo P; Jara-Albarrán A; Meoro A; del Peso C; Arribas L; Iglesias P; Caballero J; Serrano J; Picó A; Pomares F; Giménez G; López-Mondéjar P; Castello R; Merante-Boschin I; Pelizzo MR; Mauricio D; Opocher G; Rodríguez-Antona C; González-Neira A; Matías-Guiu X; Santisteban P; Robledo M
PLoS Genet; 2009 Sep; 5(9):e1000637. PubMed ID: 19730683
[TBL] [Abstract][Full Text] [Related]
17. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.
Kang J; Deng XZ; Fan YB; Wu B
Tumour Biol; 2014 Jul; 35(7):7085-96. PubMed ID: 24756757
[TBL] [Abstract][Full Text] [Related]
18. FOXE1 polyalanine tract length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid.
Szczepanek E; Ruchala M; Szaflarski W; Budny B; Kilinska L; Jaroniec M; Niedziela M; Zabel M; Sowinski J
Horm Res Paediatr; 2011; 75(5):329-34. PubMed ID: 21311165
[TBL] [Abstract][Full Text] [Related]
19. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
Takahashi M; Saenko VA; Rogounovitch TI; Kawaguchi T; Drozd VM; Takigawa-Imamura H; Akulevich NM; Ratanajaraya C; Mitsutake N; Takamura N; Danilova LI; Lushchik ML; Demidchik YE; Heath S; Yamada R; Lathrop M; Matsuda F; Yamashita S
Hum Mol Genet; 2010 Jun; 19(12):2516-23. PubMed ID: 20350937
[TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
